» Articles » PMID: 36147110

Hyperoxia in the Management of Respiratory Failure: A Literature Review

Overview
Publisher Wolters Kluwer
Specialty Medical Education
Date 2022 Sep 23
PMID 36147110
Authors
Affiliations
Soon will be listed here.
Abstract

Management of respiratory failure is closely related to oxygen supplementation. Thus, its administration needed special attention according to indications to avoid the toxic effect. Oxygen supplementation in conditions of respiratory failure aims to overcome hypoxemia. Excessive oxygen exposure can cause oxygen toxicity and lead to hyperoxia. Hyperoxia is a condition in which there is an excess supply of oxygen in the tissues and organs. Clinically, respiratory failure is diagnosed if the PaO2 is less than 60 mmHg with or without an increase in carbon dioxide when the patient breathes room air. Respiratory failure is divided into acute (sudden) respiratory failure and chronic (slow) respiratory failure. The basis for managing respiratory failure consists of supportive/non-specific and causative/specific management. Oxygen should be prescribed wisely not to cause injury to organs such as the heart, lungs, eyes, nervous system, and others. Hyperoxia often occurs in managing respiratory failure, so it requires supervision, especially in administering oxygen. Oxygen should be given as needed to avoid hyperoxia. In oxygen therapy, it is necessary to pay attention to the patient's condition because each condition requires different oxygen concentrations, so dose adjustments are necessary. These conditions can be divided into critical, severe, and observation conditions. The target oxygen saturation in all these conditions is 94-98%.

Citing Articles

Hyperoxia-Induced Secondary Respiratory Failure in a Systemic Ischaemia-Reperfusion Injury.

Okuma Y, Becker L, Yagi T, Tanda A, Suzuki K, Shimoda K Adv Exp Med Biol. 2024; 1463:173-177.

PMID: 39400819 DOI: 10.1007/978-3-031-67458-7_29.


Hyperoxia in Sepsis and Septic Shock: A Comprehensive Review of Clinical Evidence and Therapeutic Implications.

Paunikar S, Chakole V Cureus. 2024; 16(9):e68597.

PMID: 39371803 PMC: 11452320. DOI: 10.7759/cureus.68597.


Comparison of Injury Severity Score (ISS) and New Injury Severity Score (NISS) in the Evaluation of Thoracic Trauma Patients: A Retrospective Cohort Study.

Jin H, Zhang Y, Zhang Q, Ouyang L, Li X, Zhang Y Emerg Med Int. 2024; 2024:4861308.

PMID: 39220548 PMC: 11364476. DOI: 10.1155/2024/4861308.


The association of arterial partial oxygen pressure with mortality in critically ill sepsis patients: a nationwide observational cohort study.

Hyun D, Ahn J, Huh J, Hong S, Koh Y, Oh D Crit Care. 2024; 28(1):187.

PMID: 38816883 PMC: 11140987. DOI: 10.1186/s13054-024-04960-w.


NADPH Oxidase 3: Beyond the Inner Ear.

Herb M Antioxidants (Basel). 2024; 13(2).

PMID: 38397817 PMC: 10886416. DOI: 10.3390/antiox13020219.


References
1.
Dias-Freitas F, Metelo-Coimbra C, Roncon-Albuquerque Jr R . Molecular mechanisms underlying hyperoxia acute lung injury. Respir Med. 2016; 119:23-28. DOI: 10.1016/j.rmed.2016.08.010. View

2.
Vo P, Kharasch V . Respiratory failure. Pediatr Rev. 2014; 35(11):476-84. DOI: 10.1542/pir.35-11-476. View

3.
Chawla A, Lavania A . OXYGEN TOXICITY. Med J Armed Forces India. 2016; 57(2):131-3. PMC: 4925834. DOI: 10.1016/S0377-1237(01)80133-7. View

4.
MacIntyre N . Supporting oxygenation in acute respiratory failure. Respir Care. 2012; 58(1):142-50. DOI: 10.4187/respcare.02087. View

5.
ODriscoll B, Howard L, Earis J, Mak V . British Thoracic Society Guideline for oxygen use in adults in healthcare and emergency settings. BMJ Open Respir Res. 2017; 4(1):e000170. PMC: 5531304. DOI: 10.1136/bmjresp-2016-000170. View